Pulmonary Health in Children With Down Syndrome
Study Details
Study Description
Brief Summary
The goal of the study is to learn more about tests that can assess lung health in children with Down syndrome.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Children with Down syndrome and aspiration Outcomes will be compared between two groups although no intervention is submitted, this is an observational study. |
|
Children with Down syndrome without aspiration Outcomes will be compared between two groups although no intervention is submitted, this is an observational study. |
Outcome Measures
Primary Outcome Measures
- Total airway resistance [Baseline]
Airway resistance (R5) measured using forced oscillation technique at 5 Hertz
- Airway reactance [Baseline]
Airway reactance (X5) measured using forced oscillation technique at 5 Hertz
Secondary Outcome Measures
- Change in total airway resistance after albuterol [Baseline]
Airway resistance (R5) measured using forced oscillation technique at 5 Hertz before and after administration of albuterol
- Change in airway reactance after albuterol [Baseline]
Airway reactance (X5) measured using forced oscillation technique at 5 Hertz before and after administration of albuterol
- Health-related quality of life, as measured by the Pediatric Quality of Life Inventory [Baseline]
The Pediatric Quality of Life Inventory (PedsQL) assesses four domains of quality of life. Results are converted to a score from 0-100, where low numbers are low quality of life and higher numbers is better quality of life.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Children aged 3 to 18 years, inclusive, at time of consent
-
Diagnosis of Down syndrome/trisomy 21 or mosaicism
-
Able to walk
-
Had a swallow study (video fluoroscopic swallow study or fiberoptic endoscopic evaluation of swallowing) performed within 5 years of consent date
Exclusion Criteria:
-
Pregnant or lactating
-
Nonambulatory
-
Have a tracheostomy or other known severe glottic or subglottic obstruction that would significantly affect the results of testing
-
Have a significant acute respiratory illness, defined as treatment with steroids, antibiotics, or an increase in supplemental oxygen
-
have a medical illness that would a)increase the risk the participate would incur by participating in the study, b) interfere with the outcomes of the study, or c) interfere with the performance of study participants
-
Have a severe behavioral problem that would interfere with the performance of study procedures
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Children's Hospital Colorado | Aurora | Colorado | United States | 80045 |
Sponsors and Collaborators
- University of Colorado, Denver
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Emily DeBoer, MD, MSCS, University of Colorado, Denver
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 19-2092
- R21HL151261-01